2022
DOI: 10.1111/jdv.17925
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous reactions due to Pfizer's BNT162b2 mRNA and Moderna's mRNA‐1273 vaccines

Abstract: Dear Editor,The clinical trials for the Moderna and Pfizer COVID-19 vaccines reported local injection site cutaneous reactions 1,2 ; however, varied cutaneous reactions have been noted including delayed large local cutaneous reaction called 'COVID arm' and rashes characterized by their dermatologic morphological equivalents including urticarial, morbilliform, pernio/chilblains-like and pityriasis rosea-like reactions. [3][4][5]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
1
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 8 publications
0
1
1
Order By: Relevance
“…Whereas "COVID arm" usually resolves within 1 or 2 weeks, generalized ADRs lasted in many patients in our cohort for more than 28 days and in some patients even longer than 6 months. This duration is longer than the data reported by other groups, which observed regression of ADRs in most patients within 14 days [5,6,28,29]. In V-REPP, however, longer duration times of up to 49 days and rarely up to 90 days were reported.…”
Section: Discussioncontrasting
confidence: 58%
See 1 more Smart Citation
“…Whereas "COVID arm" usually resolves within 1 or 2 weeks, generalized ADRs lasted in many patients in our cohort for more than 28 days and in some patients even longer than 6 months. This duration is longer than the data reported by other groups, which observed regression of ADRs in most patients within 14 days [5,6,28,29]. In V-REPP, however, longer duration times of up to 49 days and rarely up to 90 days were reported.…”
Section: Discussioncontrasting
confidence: 58%
“…Our cohort differs in two epidemiologic aspects from other studies. In our cohort, the gender distribution is equal, whereas other studies reported a higher number of ADRs in women [6,9,17,23,26,28]. Second, the vast majority of our patients (75%) had received the mRNA-1273 vaccine, as in Switzerland far more people in general were vaccinated with mRNA-1273 [4].…”
Section: Discussionmentioning
confidence: 70%
“…Whereas 'COVID arm' usually resolves within 1 or 2 weeks, generalized ADRs lasted in our cohort in many patients for more than 28 days and in some patients even longer than 6 months. This duration is longer than the data reported by other groups which observed regression of ADRs in most patients within 14 days [5,6,28,29]. In V-REPP, however, longer duration times of up to 49 days and rarely up to 90 days were reported.…”
Section: Discussioncontrasting
confidence: 57%